Elomatic India is a turnkey engineering & consulting company dedicated to the pharmaceutical & biotech industry. It is a Joint Venture of Elomatic Oy, Finland. Elomatic is a multidiscipline industrial engineering, consulting, and software Design Company from Finland and the Pharmaceutical & Biotech sector is the key focused SBU of their process division.

Are you expanding your Pharmaceutical Facility?

Are you building a new Pharmaceutical Facility?

Conceptual Design
Plot Plan/Site Master Plan
Basic Engineering
Procurement Consultancy
Supply Chain Process
Detailed Engineering
Validation Philosophy
CSV
System Architecture for Process
Automation
Site Management
Methodology
In-House Software
Document Management

Main Entrance

Truck Entry

Click on the icons for more info

Building 6

Antibiotics Plant

Building 5

Penicillin Plant

Building 2

Laboratory and laundry

Building 1

Main office and entrance

Building 3

Utilities

Building 7

Tablets and capsule plant

Building 8

LVP (Large Volume Parenterals) and SVSP (Small volume Sterile Products) plants

Building 4

Effluent plant and rejected material storage

Building 11

Main Storage

Building 10

Inhaler Plant

Building 9

Suppositories, Ointment, Suspension and Syrup plant

Building 1:

Main office and entrance

Building 2:

Laboratory and laundry

Building 3:

Utilities

Building 4:

Effluent plant and rejected material storage

Building 5:

Penicillin Plant

Building 6:

Antibiotics plant

Building 7:

Tablets and capsule plant

Building 8:

LVP (Large Volue Parenterals) and SVSP (Small volume Sterile Products) plants

Building 9:

Suppositories, Ointment, Suspension and Syrup plant

Building 10:

Inhaler Pant

Building 11:

Main Storage

Go to article: Home | Deep BreathGo to article: In this issueGo to article: Scandinavian Health Ltd Company InsightGo to article: Scandinavian Health Ltd.Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: Hapa Company InsightGo to article: NewsGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: The pharma industry briefingGo to article: Molnar Company InsightGo to article: MolnarGo to article: A costly oversight: the ongoing impact of the valsartan recallGo to article: MedelpharmGo to article: Not so elementary, Watson: the roadblocks for AI in pharmaGo to article: ZenatekGo to article: The Petri dish: telling the story of pharma’s most humble ally Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Exploring the causal link between herpes and Alzheimer’s Go to article: Pfeiffer VacuumGo to article: antiSMASH: on the hunt for new antibioticsGo to article: PfanstiehlGo to article: Tackling consequences of air pollution with drug R&DGo to article: SanofiGo to article: Trends for 2019: from global studies to digital therapeuticsGo to article: EventsGo to article: Next issue